Supported in part by Arkansas Blue Cross and Blue Shield

Slides:



Advertisements
Similar presentations
Best Practice Tom Shiffler, MD 7/23/10
Advertisements

Antiepileptic Drugs and Suicidality: Background Evelyn Mentari, M.D., M.S. Clinical Safety Reviewer Division of Neurology Products/CDER Food and Drug Administration.
Chronic Pain Management Elaine Wendt, MD. Pain is now “Fifth Vital Sign”
CNS Depressants: Sedative-Hypnotics Chapter 6
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Antianxiety Agents.
Copyright © 2015 Cengage Learning® 1 Chapter 19 Analgesics, Sedatives, and Hypnotics.
Specific Clinical/Regulatory Issues in Development of Drugs for Peripheral Neuropathy and Neuropathic Pain Gerald J. Dal Pan, MD, MHS Medical Officer Division.
Treatment of Chronic Non-Cancer Pain Ross Bryan Mercer University MS III August 2012.
6th Annual EOOC/NSS Workers' Comp Seminar 2/26/ The Role of Adjuvant Medications in the Treatment of the Injured Worker Benjamin G Benner, MD, FACS.
CIWA Protocol: Fraser Health
An Educational Perspective Based on Information Contained In The Indiana Prevention Resource Center Factline on Benzodiazepines ®
 BNZ-1 r.: sedation, hypnotic, antianxiety  BNZ-2 r.: anxiolysis, muscle relaxation, sedation, anticonvulsant, psychomotor impairment  BNZ-3 r.: tolerance,
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
CNS Depressants: Sedative-Hypnotics Chapter 6
Ch 8 Drugs for Central Nervous System Disorders Epilepsy Parkinson Disease Other Central Nervous System Disorders Other Central Nervous System Disorders.
Anti-Anxiety Medications Brian Ladds, M.D.. Anti-Anxiety Medications 1903: first barbiturate introduced in U.S. –e.g., pentobarbital (Nembutal), amobarbital.
Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07.
Pharmacotherapy in Psychotic Disorders. Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: –
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Ph: Disclaimer: Information on this page is not a substitute for medical consultation.
Substance abuse. Substance abuse, dependence, withdrawal, tolerance, and demographics Substance abuse, dependence, withdrawal, tolerance, and demographics.
© Copyright Annals of Internal Medicine, 2009 Ann Int Med. 163 (6): ITC6-1. In the Clinic Restless Legs Syndrome.
UCLA Brain Institute Outreach Adrina Kocharian and Rachel Oseas.
 Librium is mainly indicated to manage moderate to severe anxiety. It contains generic Chlordiazepoxide as a main therapeutic agent and it belongs to.
Va Bene Neurontin 300 Per Attacco Cervicale Cheap Gabapentin Online neurontin urban dictionary gabapentin fibromyalgia 2011 gabapentin compared to oxycodone.
Finding Mental Health Information Kate Flewelling, MLIS Outreach Coordinator National Network of Libraries of Medicine, Middle Atlantic Region.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Clear the Clutter: Sage Advice on De-Prescribing Kimberly Wintemute MD CCFP FCFP National Primary Care Co-Lead Annual Clinic Day in Family Medicine, London.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Ready to Use, Basic Psychopharmacology Didactic Curriculum 2014 Behavioral Sciences in Family Medicine Conference Yvonne Murphy, MD Associate Program Director.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Substance Abuse Chapter 11. Substance Abuse  Self-administration of a drug in a manner that does not conform to the norms within the patient’s own culture.
December 10, 2015 Arthur Robin Williams MD MBE American Academy of Addiction Psychiatry Division on Substance Abuse Department of Psychiatry, Columbia.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
What Is The Dosage Of Gabapentin For Night Sweats Neurontin Online Coupon gabapentin for insomnia and anxiety gabapentin hemorrhoids gabapentin medication.
Examining Potential Misuse of Gabapentin Among Patients Admitted to an Inpatient Behavioral Health Unit Samuel Kubas a, Pharm.D. Candidate 2018; Lucas.
THE OPIOID CRISIS Mississippi Board of Nursing
Medication-Assisted Therapy at Coleman Profession Services
Drugs.
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Supported in part by Arkansas Blue Cross and Blue Shield
Presented by J. Arzaga, MSN, RN
Opioid Prescribing & Monitoring
U.P. Health Strategies May 8, 2018.
Drugs Affecting the Central Nervous System
Spasticity Treatment Options
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Duloxetine Flavio Guzman, MD.
Supported in part by Arkansas Blue Cross and Blue Shield
Supported in part by Arkansas Blue Cross and Blue Shield
What are the current guidelines for healthy living
CNS Depressants: Sedative-Hypnotics Chapter 6
Supported in part by Arkansas Blue Cross and Blue Shield
Off-label use means all uses of a marketed drug not detailed in the summary of the product characteristics including therapeutic indication, use in age-
Supported in part by Arkansas Blue Cross and Blue Shield
CNS Depressants: Sedative-Hypnotics Chapter 6
Supported in part by Arkansas Blue Cross and Blue Shield
Supported in part by Arkansas Blue Cross and Blue Shield
Supported in part by Arkansas Blue Cross and Blue Shield
Academic Detailing (AD): A New Resource From AR-IMPACT
ADDICTION
Supported in part by Arkansas Blue Cross and Blue Shield
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Medically assisted treatment
Medication Assisted Treatment of Opioid Use Disorder
Pregabalin An Overview
Opioid Stewardship Johnathan Goree, MD
Supported in part by Arkansas Blue Cross and Blue Shield
Presentation transcript:

Supported in part by Arkansas Blue Cross and Blue Shield and the Office of the Arkansas Drug Director and in partnership with the Arkansas Academy of Family Physicians (AAFP), the Arkansas Medical Society (AMS), the Arkansas State Medical Board (ASMB), the Arkansas Department of Health (ADH) and its Division of Substance Misuse and Injury Prevention (Prescription Drug Monitoring Program—PDMP) Continuing Education Credit: TEXT: 501-406-0076 Event ID:32802-30782

Gabapentin and Pregabalin: Indications and Abuse Shona Ray-Griffith, MD Assistant Professor University of Arkansas for Medical Sciences

Disclosures I receive clinical trial support from Neuronetics. I have received clinical trial support from Sage Therapeutics. Neither will be discussed today.

Objectives Discuss pharmacology and FDA indications for gabapentin Discuss pharmacology and FDA indications for pregabalin Describe abuse of gabapentin and pregabalin

Poll Everywhere Text shonaraygrif105 to 22333

https://www. polleverywhere https://www.polleverywhere.com/multiple_choice_polls/RqrLKGdt9R2GtF0g2M7NA

Fuentes AV, Pineda MD, Venkata KCN Fuentes AV, Pineda MD, Venkata KCN. “Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice” Pharmacy (Basel) 2018;6(2):43

https://www. polleverywhere https://www.polleverywhere.com/multiple_choice_polls/M9QkEcnA2yOQPxJT0T0fT

Pharmacology of Gabapentin GABA analog Does NOT bind to GABA receptor or affect GABA binding, synthesis, uptake, or degradation Does exert a neuronal inhibitory effect by blocking presynaptic voltage-dependent calcium channels Peak plasma concentration occurs 3 hours after oral ingestion Renal elimination Half-life of 5-7 hours

https://www.polleverywhere.com/free_text_polls/MxYJ7k9CaqD8ZalQLUbp0

Uses of Gabapentin Alcohol use disorder Alcohol withdrawal Chronic refractory cough Hiccups Chronic pruritus Vasomotor symptoms a/w menopause Social anxiety disorder* Focal (partial) seizures Postherpetic neuralgia Fibromyalgia Neuropathic pain Restless legs syndrome Postoperative pain

Guidelines for Neuropathic Pain European Federation of Neurological Societies (EFNS) recommends gabapentin as first-line therapy for diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. National Institute for Health and Care Excellence (NICE), Canadian Pain Society (CPS), and NeuPSIG (by the International Association for the Study of Pain) guidelines recommend gabapentin as first line therapy for all neuropathic pain.

2014 Lawsuits

Pharmacology of Pregabalin GABA analog Does NOT bind to GABA receptor or affect GABA binding, synthesis, uptake, or degradation Does exert a neuronal inhibitory effect by blocking presynaptic voltage-dependent calcium channels inhibits excitatory neurotransmitter release, including glutamate, NE, serotonin, dopamine, substance P, and calcitonin gen-related peptide) Antinociceptive and anticonvulsant activity Peak plasma concentration occurs 3 hours after oral ingestion Renal elimination Half-life of 6.3 hours Schedule V drug

https://www.polleverywhere.com/free_text_polls/5zqQZ3iNBlxAf3yBX81Xa

Uses of Pregabalin Chronic refractory cough Generalized anxiety disorder Chronic pruritus Focal (partial) seizures Social anxiety disorder Vasomotor symptoms a/w menopause Fibromyalgia Neuropathic pain Diabetic neuropathy Postherpetic neuralgia Spinal cord injury-associated neuropathic pain Critically ill patients Postoperative pain Restless legs syndrome

https://www. polleverywhere https://www.polleverywhere.com/multiple_choice_polls/gNXDrMKk3VoVzX24TgIZR

https://www. polleverywhere https://www.polleverywhere.com/multiple_choice_polls/3Ub38DybtsXUUJ08jD5Sd

Abuse of Gabapentin Smith RV, Havens JR, Walsh SL. “Gabapentin misuse, abuse and diversion: A systematic review” Addiction 2016;111:1160-1174. Gabapentin misuse ranged from 15-22% Gabapentin abuse with a prescription ranged from 40-65% Prescriptions from a provider are main source of diversion Used in combination with benzodiazepines, opioids, and alcohol Cutting agent for heroin Use for 1) recreational, 2) self-harm, and 3) self-medication

Abuse/Dependence of Gabapentin Mersfelder TL and Nichols WH. “Gabapentin: Abuse, Dependence, and Withdrawal” Annals of Pharmacotherapy 2016; 50(3):229-233 Abuse and dependence: 8 case reports All had history of substance use disorder Potentiates the effects of opioids Replace effects of cocaine or the withdrawal symptoms from cocaine use Dosages of gabapentin ranged from 3600-7200mg/day with average of 3000mg/day Symptoms: euphoria, relaxation, delirium, sedation, confusion, fatigue

Withdrawal of Gabapentin Mersfelder TL and Nichols WH. “Gabapentin: Abuse, Dependence, and Withdrawal” Annals of Pharmacotherapy 2016; 50(3):229-233 Withdrawal Onset 24-48 hours after last use (doses of 500-8000mg daily) Symptoms: agitation (>50%), confusion and disorientation (45%), diaphoresis (36%), GI symptoms (23%), tremor (18%), tachycardia (18%), HTN (18%), insomnia (14%) Isolated reports of akathisia, catatonia, and seizures Treatment: reinstate gabapentin

Gabapentin/Pregabalin Abuse Hakkinen M, Vuori E, Kalso E, Gergov M, Ojanpera I. “Profiles of pregabalin and gabapentin by postmortem toxicology” Forensic Science International 2014; 241:1-6. 2010-2011: Toxicology reports on 13,766 cases out of 101,472 deaths (13.6%) Pregabalin positive in 2.3% of toxicology investigated reports Gabapentin positive in 0.31% of toxicology investigated reports 91% of deceased pregabalin users and 88% of deceased gabapentin users were also positive for opioids Users were significantly younger (under 30 years) In all cases, other drugs were found.

Street Rx Gabapentin Pregablin $1-2/pill for 300mg to 800mg pills $20 for 75mg pill

https://www. polleverywhere https://www.polleverywhere.com/multiple_choice_polls/wbVThKjzgRO7ttRMjQ0Du

Questions about the Topic Continuing Education Credit: TEXT: 501-406-0076 Event ID: 32802-30782

Case Conference and Feedback Continuing Education Credit: TEXT: 501-406-0076 Event ID: 32802-30782